Category Archives: Avastin

Featured Stories

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

New York Man Claims Biomet Metal-on-Metal Hip Implant Caused Pain, Disability

A New York man claims his metal-on-metal hip implant was defective and required replacement within a year of receiving it. This has left him facing a lifetime of pain, disability, and rising medical costs.

Read More

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

Three people, including a train engineer, were injured on Wednesday when a Long Island Rail Road train hit a livery cab on the tracks west of Wyandanch station, LIRR officials said. LIRR spokesman Salvatore Arena said the driver of the Lincoln Town Car was taken to Good Samaritan Hospital Medical Center ...

Read More

Study Links Liquid in E-Cigarette to Viral Infections

Study Links Liquid in Electronic Cigarette to Increased Risk of Viral Infections

The National Jewish Health study, links the liquid used in e-cigarettes to a higher risk of respiratory viral infections, whether the liquid contains nicotine or not.

Read More

First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL

The first test trials in the federal C.R. Bard Avaulta transvaginal mesh litigation will most likely start next year, according to a report from Bloomberg News. About 600 lawsuits involving Bard Avaulta transvaginal mesh products are currently pending in the multidistrict litigation underway Charleston, West Virginia. U.S. District Judge Joseph ...

Read More

Pradaxa Associated with more Complications than Warfarin, According to Early Study Findings

Early results from the largest study to date to compare Pradaxa and warfarin indicate that in a real-world setting, Pradaxa causes more complications than decades-old warfarin. The preliminary study results were announced last week, during the 2012 Thrombosis and Hemostasis Summit of North America.

Read More

Tentative Ohio Fracking Regulations Criticized as too Lax

Lawmakers in Ohio have tentatively passed new regulations governing hydraulic fracturing (fracking) drilling but they’ve immediately been criticized for being too favorable to the natural gas and oil industries.

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed. According to press release issued Jan. 7, a resolution was introduced by Council Member Margaret Chin, Council Speaker Melissa Mark-Viverito and Council Members Paul Vallone and I. ...

Read More

Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage

A man from Tennessee has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage. The complaint alleges Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause Serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects ...

Read More

Avastin Tied to High Blood Pressure, Gastrointestinal Bleeding Risks

avastin_blood_pressure_link

The cancer medication, Avastin (bevacizumab), has been tied to increased episodes of hypertension (high blood pressure) and gastrointestinal bleeding, according to a recently published article. The article appears online in the August 27, 2013 issue of the journal Clinical Drug … Continue reading

Posted in Avastin, Pharmaceuticals |

U.K. Citizen Sentenced in U.S. for Distributing Fake Avastin

us_citizen_arrested_selling_fake_avastin

A British citizen was just sentenced by United States authorities to prison time and a substantial fine over distributing bogus prescription drugs. The U.S. attorney’s office for the Eastern District of Missouri said that Richard J. Taylor of Warwickshire, England … Continue reading

Posted in Avastin, Pharmaceuticals |

Study: Avastin Offers No Advantage in Treatment of Brain Cancer

news_inferno_blogimage_Avastin_Brain_Cancer

Cancer drug, Avastin (bevacizumab), did not extend survival in patients with deadly brain masses, according to an emerging study. The Roche Holding AG medication offered no advantage as a first-line therapy against glioblastoma, a type of brain cancer, according to … Continue reading

Posted in Avastin, Legal News, Pharmaceuticals |

Cancer Drug, Avastin, Recalled Over Life-Threatening Infections

Avastin_Recalled_Cancer_Drug_Infection

Hoffmann-La Roche Limited has recalled Avastin (bevacizumab) following cases of necrotizing fasciitis, some fatal, reported in patients receiving the chemotherapy drug in both clinical trials and in the post-marketing setting. Necrotizing fasciitis is a rare, life-threatening infection of the soft … Continue reading

Posted in Avastin, Pharmaceuticals |

Cancer Drug, Avastin, Used Off-Label for Macular Degeneration, Recalled for Serious Eye Infections

The U.S. Food and Drug Administration (FDA) just announced that Clinical Specialties recalled 79 lots of Avastin (bevacizumab) unit dose syringes, over the potential for serious eye infection. The recalled Avastin has, or could potentially, lead to an infection in … Continue reading

Posted in Avastin, Pharmaceuticals, Product Recalls, Recalled Drugs |

FDA warns of counterfeit Avastin distributed by New York company

Federal health officials have issued another warning about counterfeits of the cancer drug Avastin that have been distributed in the U.S. This is the third warning issued by the Food and Drug Administration in the last year about the presence … Continue reading

Posted in Avastin, Consumer Fraud, Defective Medical Devices, Defective Products, Health Concerns, Pharmaceuticals | Tagged , |

FDA Finds More Counterfeit Cancer Drugs

The U.S. Food & Drug Administration (FDA) has found more counterfeit cancer drugs, it said. A prior international counterfeit Avastin investigation spanned from California, to Turkey, to Egypt. This new scam also involves a batch of counterfeit Avastin—a cancer medication … Continue reading

Posted in Avastin, Pharmaceuticals |

Counterfeit Avastin Highlights Weak Drug Protections

The recent counterfeit Avastin debacle highlights the issue with weak drug protections. The international investigation spanned from California, to Turkey, to Egypt. Avastin is a cancer medication manufactured by Roche. Many are concerned that as drug counterfeiters fine-tune their practices, … Continue reading

Posted in Avastin, Pharmaceuticals |

Egypt May Have Been Source For Counterfeit Avastin

Egypt may have been the source for counterfeit Avastin recently discovered at U.S. health care facilities and prompting the maker of the cancer drug to warn doctors and patients about the bogus medicines. Now, authorities are trying to determine if … Continue reading

Posted in Avastin, Pharmaceuticals |

Counterfeit Avastin Discovered At U.S. Health Facilities

Counterfeit Avastin was just discovered at U.S. health care facilities, prompting the maker of the cancer drug to warn doctors and patients about the bogus medications. According to Roche’s Genentech, the fake Avastin does not contain the key ingredient in … Continue reading

Posted in Avastin, Pharmaceuticals |

© 2005-2020 Parker Waichman LLP ®. All Rights Reserved.